Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis: a meta-analysis.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of the American Medical Association (JAMA)

• Publication date

  2002-08-28

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/JAMA.288.8.996PMID 12190370
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of subinhibitory concentrations of antibiotics on extracellular shiga-like toxin I

  2005cited by this paper
• Statistical methods in cancer research

  2001cited by this paper
• The central Scotland Escherichia coli O157:H7 outbreak: risk factors for the hemolytic uremic syndrome and death among hospitalized patients.

  2001cited by this paper
• Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.

  2001cited by this paper
• Leukocytosis in children with Escherichia coli O157:H7 enteritis developing the hemolytic‐uremic syndrome

  2000cited by this paper
• The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections.

  2000cited by this paper
• Macrolides and clindamycin suppress the release of Shiga-like toxins from Escherichia coli O157:H7 in vitro.

  2000cited by this paper
• Thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.

  2000cited by this paper
• E. coli, antibiotics, and the hemolytic-uremic syndrome.

  2000cited by this paper
• Effect of Antibiotics, Levofloxacin and Fosfomycin, on a Mouse Model with Escherichia coli O157 Infection

  2000cited by this paper
• [Therapeutic effects of antibiotics against enterohemorrhagic Escherichia coli (EHEC) O157:H7 (O157) infection: in vivo analysis using germfree mice].

  1999cited by this paper
• Is Antibiotic Therapy of Mice and Humans Useful in Escherichia coli O157 : H7 Enteritis?

  1999cited by this paper
• Chemotherapy for enterohemorrhagic Escherichia coli O157:H infection in a mouse model.

  1999cited by this paper
• Escherichia coli O157:H7 outbreak associated with an improperly chlorinated swimming pool.

  1999cited by this paper
• Effect of early fosfomycin treatment on prevention of hemolytic uremic syndrome accompanying Escherichia coli O157:H7 infection.

  1999cited by this paper
• Efficacy of Antibiotic Therapy for Infection with Shiga-Like Toxin-Producing Escherichia coli O157 : H7 in Mice with Protein-Calorie Malnutrition

  1999cited by this paper
• Effectiveness of therapeutic plasma exchange in the 1996 Lanarkshire Escherichia coli O157:H7 outbreak.

  1999cited by this paper
• Effect of early oral fluoroquinolones in hemorrhagic colitis due to Escherichia coli O157:H7

  1999cited by this paper
• The pathophysiology of the hemolytic uremic syndrome.

  1999cited by this paper
• Risk factors for the development of Escherichia coli O157:H7 associated with hemolytic uremic syndrome

  1999cited by this paper
• Clinical experiences in Sakai City Hospital during the massive outbreak of enterohemorrhagic Escherichia coli O157 infections in Sakai City, 1996

  1999cited by this paper
• Strain-Specific Differences in the Amount of Shiga Toxin Released from Enterohemorrhagic Escherichia coli O157 following Exposure to Subinhibitory Concentrations of Antimicrobial Agents

  1998cited by this paper
• Escherichia coli O157 interactions with human intestinal Caco-2 cells and the influence of fosfomycin.

  1998cited by this paper
• Early use of fosfomycin for Shiga Toxin-Producing Escherichia coli O157 infection reduces the risk of Hemolytic-Uremic syndrome

  1998cited by this paper
• [Retrospective analysis of the relationship between HUS incidence and antibiotics among patients with Escherichia coli O157 enterocolitis in the Sakai outbreak].

  1998cited by this paper
• A nationwide case-control study of Escherichia coli O157:H7 infection in the United States.

  1998cited by this paper
• Risk of hemolytic uremic syndrome after sporadic Escherichia coli O157:H7 infection: results of a Canadian collaborative study. Investigators of the Canadian Pediatric Kidney Disease Research Center.

  1998cited by this paper
• Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157:H7 infections.

  1997cited by this paper
• Bias in meta-analysis detected by a simple, graphical test

  1997cited by this paper
• [The old and new problems of the antibiotics treatment in hemorrhagic enterocolitis and hemolytic uremic syndrome, according to Japanese epidemiological studies].

  1997cited by this paper
• Effect of antimicrobial agents, especially fosfomycin, on the production and release of Vero toxin by enterohaemorrhagic Escherichia coli O157:H7.

  1997cited by this paper
• 腸管出血性大腸菌感染症における溶血性尿毒症症候群 (HUS) 合併の予期因子と合併予防のための早期集約的治療について

  1997cited by this paper
• Escherichia coli O157:H7 and the hemolytic-uremic syndrome.

  1995cited by this paper
• Incomplete hemolytic-uremic syndrome in Argentinean children with bloody diarrhea.

  1995cited by this paper
• A 20-year population-based study of postdiarrheal hemolytic uremic syndrome in Utah.

  1994cited by this paper
• A continuing assessment of risk factors for the development of Escherichia coli O157:H7-associated hemolytic uremic syndrome.

  1994cited by this paper
• An outbreak of diarrhea and hemolytic uremic syndrome from Escherichia coli O157:H7 in fresh-pressed apple cider.

  1993cited by this paper
• Randomized, controlled trial of antibiotic therapy for Escherichia coli O157:H7 enteritis.

  1992cited by this paper
• The epidemiology and clinical aspects of the hemolytic uremic syndrome in Minnesota.

  1990cited by this paper
• Risk factors for the progression of Escherichia coli O157:H7 enteritis to hemolytic-uremic syndrome.

  1990cited by this paper
• Hemolytic-uremic syndrome during an outbreak of Escherichia coli O157:H7 infections in institutions for mentally retarded persons: clinical and epidemiologic observations.

  1990cited by this paper
• Infections with Escherichia coli O157:H7 in Washington State. The first year of statewide disease surveillance.

  1989cited by this paper
• Illnesses associated with Escherichia coli O157:H7 infections. A broad clinical spectrum.

  1988cited by this paper
• A severe outbreak of Escherichia coli O157:H7--associated hemorrhagic colitis in a nursing home.

  1987cited by this paper
• Hemolytic uremic syndrome and diarrhea associated with Escherichia coli 0157:H7 in a day care center

  1986cited by this paper
• Early treatment with erythromycin of Campylobacter jejuni-associated dysentery in children.

  1986cited by this paper
• Growth of Escherichia coli in the presence of trimethoprim-sulfamethoxazole facilitates detection of Shiga-like toxin producing strains by colony blot assay

  1986cited by this paper
• Hemolytic uremic syndrome and diarrhea associated with Escherichia coli O157:H7 in a day care center.

  1986cited by this paper
• Escherichia coli O157:H7 diarrhea in a nursing home: clinical, epidemiological, and pathological findings.

  1986cited by this paper
• The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli.

  1985cited by this paper
• The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. 1985.

  1985cited by this paper
• Prevention of travelers' diarrhea with trimethoprim-sulfamethoxazole and trimethoprim alone.

  1983cited by this paper
• Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools.

  1983cited by this paper
• Statistical methods in cancer research: volume 1- The analysis of case-control studies

  1980cited by this paper
• [Hemolytic-uremic syndrome].

  1973cited by this paper
• Double-blind treatment study of shigellosis comparing ampicillin, sulfadiazine, and placebo.

  1967cited by this paper
• Statistical aspects of the analysis of data from retrospective studies of disease.

  1959cited by this paper

• Impact of antibiotic treatment on hemolytic uremic syndrome risk in Escherichia coli O157 infections: a comprehensive systematic review and meta-analysis

  2025cites this paper
• The toll of exclusion from work or preschool due to toxin-producing Escherichia coli positivity in Dublin and South East Ireland, 2022/2023.

  2025cites this paper
• The Prognostic Role of Serum Procalcitonin for Adult Patients with Acute Diarrhea in the Emergency Department

  2025cites this paper
• Do asymptomatic STEC-long-term carriers need to be isolated or decolonized? New evidence from a community case study and concepts in favor of an individualized strategy

  2024cites this paper
• Screening and Identification of Natural Compounds as Potential Inhibitors of Glutamate Racemase and an Emerging Drug Target of Food Pathogen E. coli O157:H7: An In silico Approach to Combat Increasing Drug Resistance.

  2024cites this paper
• A prophage encoded ribosomal RNA methyltransferase regulates the virulence of Shiga-toxin-producing Escherichia coli (STEC)

  2023cites this paper
• Overview of Side-Effects of Antibacterial Fluoroquinolones: New Drugs versus Old Drugs, a Step Forward in the Safety Profile?

  2023cites this paper
• Uncommon Causes of Acute Kidney Injury.

  2022cites this paper
• Survival and Virulence Potential of Drug-Resistant E. coli in Simulated Gut Conditions and Antibiotic Challenge

  2022cites this paper
• Molecular Lipopolysaccharide Di-Vaccine Protects from Shiga-Toxin Producing Epidemic Strains of Escherichia coli O157:H7 and O104:H4

  2022cites this paper
• Diagnosis and Treatment for Shiga Toxin-Producing Escherichia coli Associated Hemolytic Uremic Syndrome

  2022cites this paper
• A Macroporous Magnesium Oxide-Templated Carbon Adsorbs Shiga Toxins and Type III Secretory Proteins in Enterohemorrhagic Escherichia coli, Which Attenuates Virulence

  2022cites this paper
• Management des hämolytisch-urämischen Syndroms beim Kind

  2021cites this paper
• Propionic acid induces apoptosis‐like death in Escherichia coli O157

  2021cites this paper
• Integrated Approach for the Diagnosis of Shiga Toxin-Producing Escherichia coli Infections in Humans.

  2021cites this paper
• Role of Recent Therapeutic Applications and the Infection Strategies of Shiga Toxin-Producing Escherichia coli

  2021cites this paper
• Azithromycin Resistance in Shiga Toxin-Producing Escherichia coli in France between 2004 and 2020 and Detection of mef(C)-mph(G) Genes

  2021cites this paper
• Why antibiotics should not be used to treat Shiga toxin-producing Escherichia coli infections

  2021cites this paper
• Agritourism and Kidding Season: A Large Outbreak of Human Shiga Toxin-Producing Escherichia coli O157 (STEC O157) Infections Linked to a Goat Dairy Farm—Connecticut, 2016

  2021influential citation
• ACCEPTED AUTHOR VERSION OF THE MANUSCRIPT: Meta-analysis of Escherichia coli O157 prevalence in foods of animal origin in Turkey

  2020cites this paper
• Typical and Atypical Hemolytic Uremic Syndrome in the Critically Ill.

  2020cites this paper
• Shiga-Toxin E. coli Hemolytic Uremic Syndrome: Review of Management and Long-term Outcome

  2020cites this paper
• Escherichia, Shigella, and Salmonella

  2020cites this paper
• Meta-analysis of Escherichia coli O157 prevalence in foods of animal origin in Turkey

  2020cites this paper
• Shiga Toxin-Associated Hemolytic Uremic Syndrome: A Narrative Review

  2020cites this paper
• Diarrea ematica nel bambino… pensa alla sindrome emolitico-uremica!

  2020cites this paper
• Shiga toxin-producing Escherichia coli associated hemolytic uremic syndrome (STEC-HUS)

  2020cites this paper
• Hemolytic uremic syndrome caused by Shiga toxin–producing Escherichia coli in children: incidence, risk factors, and clinical outcome

  2020cites this paper
• Anti-biofilm and Antibacterial Activity of Allium sativum Against Drug Resistant Shiga-Toxin Producing Escherichia coli (STEC) Isolates from Patient Samples and Food Sources

  2019cites this paper
• Shiga toxin-induced haemolytic uraemic syndrome and the role of antibiotics: a global overview.

  2019cites this paper
• Infections of the Luminal Digestive Tract

  2019cites this paper
• Syndrome hémolytique et urémique typique de l’enfant de moins de quinze ans : devenir rénal à cinq ans et facteurs pronostiques à propos d’une série monocentrique du CHU de Lille

  2019cites this paper
• Hemolytic Uremic Syndrome

  2019cites this paper
• Cross-reacting surface proteins between different Escherichia coli O157:H7 strains and their immune responses in animal models

  2019cites this paper
• Hemolytic uremic syndrome in a developing country: Consensus guidelines

  2019cites this paper
• Transcriptional and Translational Inhibitors Block SOS Response and Shiga Toxin Expression in Enterohemorrhagic Escherichia coli

  2019cites this paper
• Hemolytic Uremic Syndrome.

  2019cites this paper
• Determination of the antibiotic resistance and bacteriophage infectivity of verocytotoxigenic Escherichia coli

  2019cites this paper
• An outbreak of hemolytic uremic syndrome in southern Romania during 2015-2016: Epidemiologic, clinical, laboratory, microbiologic, therapeutic and outcome characteristics.

  2019cites this paper
• Recent Prescription Patterns for Children With Acute Infectious Diarrhea

  2019cites this paper
• Haemolytic uremic syndrome: diagnosis and management

  2019cites this paper
• Guideline for the Antibiotic Use in Acute Gastroenteritis

  2019cites this paper
• Syndromes hémolytiques et urémiques de l’adulte

  2018cites this paper
• Non-O157 Shiga toxin-producing Escherichia coli-A poorly appreciated enteric pathogen: Systematic review.

  2018cites this paper
• Development of Novel Multifunctional Nanocomposites for Antimicrobial Efficiency in Water Treatment

  2018cites this paper
• 57 – Inflammatory Enteritis

  2018cites this paper
• Hemolytic Uremic Syndrome in a Young Adult

  2018cites this paper
• Lactoferrin inhibits E. coli O157:H7 growth and attachment to intestinal epithelial cells

  2018influential citation
• JAID/JSC Guidelines for Infection Treatment 2015-Intestinal infections.

  2018influential citation
• The 2011 German Enterohemorrhagic Escherichia Coli O104:H4 Outbreak-The Danger Is Still Out There.

  2018cites this paper
• Alterations in Shiga Toxin-Producing E. coli Colonization and Virulence Following Dietary Modulation and Administration of Antimicrobials

  2017cites this paper
• Hemolytic uremic syndrome due to Shiga toxin-producing Escherichia coli infection.

  2017cites this paper
• Prevalence and antimicrobial susceptibility of Escherichia coli O157 in beef at butcher shops and restaurants in central Ethiopia

  2017cites this paper
• Impact of probiotic strain of the non-pathogenic Escherichia coli “ Nissle 1917 ” on gene expression of shiga toxin E . coli O 157 : H 7 In vitro and In vivo

  2017cites this paper
• 37 – Food-Borne Diarrheal Illness

  2017cites this paper
• Haemolytic uraemic syndrome.

  2017cites this paper
• Treatment and management of children with haemolytic uraemic syndrome

  2017cites this paper
• Controlling Enterohemorrhagic E. coli O157: H7 using Selenium and Rutin

  2017cites this paper
• Infection-Associated Thrombotic Microangiopathy

  2017cites this paper
• Management of Acute Diarrheal Illness During Deployment: A Deployment Health Guideline and Expert Panel Report.

  2017cites this paper
• Enterohemorrhagic Escherichia coli Hybrid Pathotype O80:H2 as a New Therapeutic Challenge

  2016cites this paper
• Hemolytic Uremic Syndrome

  2016cites this paper
• Acute Gastroenteritis and Campylobacteriosis in Swiss Primary Care: The Viewpoint of General Practitioners

  2016cites this paper
• ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Acute Diarrheal Infections in Adults

  2016cites this paper
• Time Is of the Essence: The Impact of Delayed Antibiotic Therapy on Patient Outcomes in Hospital-Onset Enterococcal Bloodstream Infections.

  2016cites this paper
• Colistin inhibits E. coli O157:H7 Shiga-like toxin release, binds endotoxins and protects Vero cells.

  2016influential citation
• Shiga Toxin-Producing Escherichia coli Infection, Antibiotics, and Risk of Developing Hemolytic Uremic Syndrome: A Meta-analysis.

  2016influential citation
• Design and Synthesis of Molecular Scaffolds with Anti-infective Activity.

  2016cites this paper
• Disease severity of Shiga toxin-producing E. coli O157 and factors influencing the development of typical haemolytic uraemic syndrome: a retrospective cohort study, 2009–2012

  2016cites this paper
• Postinfectious Hemolytic Uremic Syndrome

  2016cites this paper
• Emerging Infectious Diseases

  2016cites this paper
• Bacterial, viral, and toxic causes of diarrhea, gastroenteritis, and anorectal infections

  2015cites this paper
• Haemolytic Uremic Syndrome in Children (1955-2015): A 60 Years Journey

  2015cites this paper
• Preparing Families With Children for International Travel.

  2015cites this paper
• HISTORY OF HAEMOLYT IC UREMIC SYNDROME

  2015cites this paper
• A role for fosfomycin treatment in children for prevention of haemolytic-uraemic syndrome accompanying Shiga toxin-producing Escherichia coli infection.

  2015cites this paper
• Renal involvement in children with HUS

  2015cites this paper
• [European Society for Pediatric Gastroenterology, Hepatology, and Nutrition/European Society for Pediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe: update 2014].

  2015cites this paper
• Renal Involvement in Children with HUS Hemolytic uremic syndrome (HUS)

  2015cites this paper
• Gastrointentinal Manifestations of Systemic Diseases

  2015cites this paper
• Approaches to treatment of emerging Shiga toxin-producing Escherichia coli infections highlighting the O104:H4 serotype

  2015cites this paper
• Possible curative role of azithromycin administration in Escherichia coli-induced nephrotoxicity of young albino rats: histological, immunohistochemical, and morphometric study

  2015cites this paper
• Antibiotic treatment of verocytotoxin-producing Escherichia coli (VTEC) infection: a systematic review and a proposal.

  2015cites this paper
• Hemolytic Uremic Syndrome Caused by Shiga Toxin-Producing Escherichia coli Infections: An Overview

  2014cites this paper
• Diagnosis and Treatment of the Hemolytic Uremic Syndrome Disease Spectrum in Developing Regions

  2014cites this paper
• Gastrointestinale Infektionen

  2014cites this paper
• Hemolytic uremic syndrome

  2014cites this paper
• Management of hemolytic uremic syndrome

  2014cites this paper
• Detection of Shiga toxin (Stx)-producing Escherichia coli (STEC) in bovine dairy herds in Northern Italy.

  2014cites this paper
• European Society for Pediatric Gastroenterology, Hepatology, and Nutrition/European Society for Pediatric Infectious Diseases Evidence-Based Guidelines for the Management of Acute Gastroenteritis in Children in Europe: Update 2014

  2014cites this paper
• Advances in pediatric pharmacology, therapeutics, and toxicology.

  2014cites this paper
• Treatment of Enterohemorrhagic Escherichia coli–Induced Hemolytic Uremic Syndrome (eHUS)

  2014cites this paper
• Lessons learned from a textbook outbreak: EHEC-O157:H7 infections associated with the consumption of raw meat products, June 2012, Limburg, Belgium

  2014cites this paper
• Der norddeutsche Ausbruch mit Shiga‐Toxin‐produzierenden E. coli O104:H4 aus klinisch‐mikrobiologischer Sicht

  2014cites this paper
• Guidelines for the management and investigation of hemolytic uremic syndrome

  2014cites this paper
• Guidelines for the management and investigation of hemolytic uremic syndrome

  2014cites this paper
• The worst of both worlds: examining the hypervirulence of the shigatoxigenic/enteroaggregative Escherichia coli O104:H4.

  2014cites this paper
• Comparisons of Native and Chimeric Shiga Toxins Indicate that the Binding Subunit Dictates Degree of Toxicity

  2014cites this paper
• Management of hemolytic-uremic syndrome in children

  2014cites this paper
• The Dilemma of Antimicrobial Treatment of Shiga Toxin-producing Escherichia coli

  2014cites this paper